AH Insider Trading Activity and SEC Form 4 Filings
AH insider trading summary
No open-market insider purchases or sales of Accretive Health, Inc. (AH) have been reported on SEC Form 4 in the past 12 months.
Latest AH insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 28, 2012 | Edgar Bronfman Jr | Director | Sell | $615K (54,900 @ $11.21) |
| Nov 27, 2012 | Edgar Bronfman Jr | Director | Sell | $795K (70,100 @ $11.34) |
| Sep 13, 2012 | Edgar Bronfman Jr | Director | Sell | $2.5M (209,700 @ $12.16) |
| Sep 12, 2012 | Edgar Bronfman Jr | Director | Sell | $530K (40,300 @ $13.16) |
| Aug 17, 2011 | Arthur H. Spiegel III | Director | Sell | $2.6M (91,931 @ $28.66) |
| Aug 16, 2011 | Arthur H. Spiegel III | Director | Sell | $1.4M (50,000 @ $28.57) |
| Mar 30, 2011 | Accretive Investors Sbic LP | 10% Owner | Sell | $43.9M (1,956,321 @ $22.44) |
| Mar 30, 2011 | Group Vi 31 LLC | 10% Owner | Sell | $18.3M (814,110 @ $22.44) |
| Mar 30, 2011 | Accretive Associates SBIC, LLC | 10% Owner | Sell | $43.9M (1,956,321 @ $22.44) |
| Mar 30, 2011 | J Taylor Crandall | 10% Owner | Sell | $18.3M (814,110 @ $22.44) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.